Key details of the duodenal-jejunal bypass in type 2 diabetes mellitus rats

被引:1
|
作者
Han, Li-Ou [1 ]
Zhou, Li-Hong [2 ]
Cheng, Su-Jun [2 ]
Song, Chun [1 ]
Song, Chun-Fang [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin 150001, Heilongjiang Pr, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Endocrinol, Harbin 150001, Heilongjiang Pr, Peoples R China
关键词
Duodenal-jejunal bypass; Type 2 diabetes mellitus; Minimally invasive surgery; Fast-track surgery; Damage control surgery; Permissive underfeeding; Goal-directed volume therapy; Y GASTRIC BYPASS; DAMAGE CONTROL; MODEL; COMPLICATIONS; MANAGEMENT; SURGERY; DISEASE; DIET;
D O I
10.3748/wjg.v17.i45.5021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate which surgical techniques and perioperative regimens yielded the best survival rates for diabetic rats undergoing gastric bypass. METHODS: We performed Roux-en-Y gastric bypass with reserved gastric volume, a procedure in which gastrointestinal continuity was reestablished while excluding the entire duodenum and proximal jejunal loop. We observed the procedural success rate, long-term survival, and histopathological sequelae associated with a number of technical modifications. These included: use of anatomical markers to precisely identify Treitz's ligament; careful dissection along surgical planes; careful attention to the choice of regional transection sites; reconstruction using full-thickness anastomoses; use of a minimally invasive procedure with prohemostatic pretreatment and hemorrhage control; prevention of hypo-thermic damage; reduction in the length of the procedure; and accelerated surgical recovery using fast-track surgical modalities such as perioperative permissive underfeeding and goal-directed volume therapy. RESULTS: The series of modifications we adopted reduced operation time from 110.02 +/- 12.34 min to 78.39 +/- 7.26 min ( P < 0.01), and the procedural success rate increased from 43.3% (13/30) to 90% (18/20) (P < 0.01), with a long-term survival of 83.3% (15/18) (P < 0.01). CONCLUSION: Using a number of fast-track and damage control surgical techniques, we have successfully established a stable model of gastric bypass in diabetic rats. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:5021 / 5027
页数:7
相关论文
共 50 条
  • [21] Type 2 diabetes mellitus control and atherosclerosis prevention in a non-obese rat model using duodenal-jejunal bypass
    Chen, Xuan
    Huang, Zhen
    Ran, Wenhua
    Liao, Gang
    Zha, Lang
    Wang, Ziwei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (03) : 856 - 862
  • [22] Effect of Endoscopic Duodenal-Jejunal Bypass Liner on Parameters of Insulin Sensitivity and Secretion in Subjects with Type 2 Diabetes Mellitus and Obesity
    Kudlackova, Michaela
    Mraz, Milos
    Haluzik, Martin
    Pelikanova, Terezie
    Benes, Marek
    Lapesova, Danuse
    Kobrova, Dana
    Vlasakova, Zuzana
    Brizova, Olga
    Lacinova, Zdenka
    DIABETES, 2019, 68
  • [23] Improvement of Type 2 Diabetes after Implantation of a Duodenal-Jejunal Bypass Liner in Obese Patients
    Betzel, B.
    Koehestanie, P.
    Dogan, K.
    Janssen, I.
    Wahab, P.
    Berends, F.
    de Boer, H.
    OBESITY SURGERY, 2013, 23 (08) : 1179 - 1180
  • [24] Moderate Effect of Duodenal-Jejunal Bypass Surgery on Glucose Homeostasis in Patients With Type 2 Diabetes
    Klein, Samuel
    Fabbrini, Elisa
    Patterson, Bruce W.
    Polonsky, Kenneth S.
    Schiavon, Carlos A.
    Correa, Jose L.
    Salles, Joao E.
    Wajchenberg, Bernardo L.
    Cohen, Ricardo
    OBESITY, 2012, 20 (06) : 1266 - 1272
  • [25] Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study
    Laubner, Katharina
    Riedel, Nina
    Fink, Katharina
    Holl, Reinhard W.
    Welp, Reinhard
    Kempe, Hans-Peter
    Lautenbach, Anne
    Schlensak, Matthias
    Stengel, Rainer
    Eberl, Thomas
    Dederichs, Frank
    Schwacha, Henning
    Seufert, Jochen
    Aberle, Jens
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1868 - 1877
  • [26] ENDOSCOPICALLY DELIVERED DUODENAL-JEJUNAL BYPASS LINER TO TREAT TYPE 2 DIABETES IN OBESE PATIENTS
    Curcio, G.
    Casu, A.
    Traina, M.
    Colanino, M. Ziino
    Tuzzolino, F.
    Vizzini, G.
    Gridelli, B.
    DIGESTIVE AND LIVER DISEASE, 2014, 46 : S143 - S143
  • [27] Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
    Shohei Okikawa
    Hideya Kashihara
    Mitsuo Shimada
    Kozo Yoshikawa
    Takuya Tokunaga
    Masaaki Nishi
    Chie Takasu
    Yuma Wada
    Toshiaki Yoshimoto
    Scientific Reports, 13
  • [28] Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
    Okikawa, Shohei
    Kashihara, Hideya
    Shimada, Mitsuo
    Yoshikawa, Kozo
    Tokunaga, Takuya
    Nishi, Masaaki
    Takasu, Chie
    Wada, Yuma
    Yoshimoto, Toshiaki
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [29] A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal-Jejunal Bypass on Type-2 Diabetes in non-Obese Rats
    Xu, Bo
    Yan, Xiaojie
    Shao, Yikai
    Shen, Qiwei
    Hua, Rong
    Ding, Rui
    Yao, Qiyuan
    OBESITY SURGERY, 2015, 25 (10) : 1966 - 1975
  • [30] The EndoBarrier: Duodenal-Jejunal Bypass Liner for Diabetes and Weight Loss
    Ruban, Aruchuna
    Ashrafian, Hutan
    Teare, Julian P.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018